BNOEF
Price:
$0.006
Market Cap:
$3.38M
Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which is in phase 2 clinical trial for the treatment of social anxiety disorder and phase 2b to treat post-traumatic stress disorder. It also develops BNC101, a monoclonal antibody that has completed phase 1 clinical trial that targets cancer stem cells; and BNC105, which is in phase 2 clinical trial for the treatment of refractory colorectal cancer and phase 1 clinical trial for the treatment o...[Read more]
Industry
Biotechnology
IPO Date
2014-06-24
Stock Exchange
PNK
Ticker
BNOEF
According to Bionomics Limited’s latest financial reports and current stock price. The company's current Enterprise Value is -9127051.00. This represents a change of -100.29% compared to the average of 3.15B of the last 4 quarters.
The mean historical Enterprise Value of Bionomics Limited over the last ten years is 5.88B. The current -9127051.00 Enterprise Value has changed -115.53% with respect to the historical average. Over the past ten years (40 quarters), BNOEF's Enterprise Value was at its highest in in the December 2021 quarter at 19.52B. The Enterprise Value was at its lowest in in the June 2024 quarter at 1.27B.
Average
5.88B
Median
3.94B
Minimum
1.47B
Maximum
11.47B
Discovering the peaks and valleys of Bionomics Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 94.75%
Maximum Annual Enterprise Value = 11.47B
Minimum Annual Increase = -65.89%
Minimum Annual Enterprise Value = 1.47B
Year | Enterprise Value | Change |
---|---|---|
2024 | 1.47B | -54.42% |
2023 | 3.22B | -65.89% |
2022 | 9.44B | -17.71% |
2021 | 11.47B | 42.79% |
2020 | 8.03B | 4.55% |
2019 | 7.68B | 94.75% |
2018 | 3.94B | 0.61% |
2017 | 3.92B | 5.28% |
The current Enterprise Value of Bionomics Limited (BNOEF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
4.71B
5-year avg
6.72B
10-year avg
5.88B
Bionomics Limited’s Enterprise Value is less than BetterLife Pharma Inc. (15.61M), less than PharmaTher Holdings Ltd. (0), less than IntelGenx Technologies Corp. (18.30M), less than Captiva Verde Wellness Corp. (45.38M), less than null (7.42M),
Company | Enterprise Value | Market cap |
---|---|---|
15.61M | $9.92M | |
0 | $14.70M | |
18.30M | $29.69M | |
45.38M | $5.34M | |
7.42M | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bionomics Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Bionomics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Bionomics Limited's Enterprise Value?
What is the highest Enterprise Value for Bionomics Limited (BNOEF)?
What is the 3-year average Enterprise Value for Bionomics Limited (BNOEF)?
What is the 5-year average Enterprise Value for Bionomics Limited (BNOEF)?
How does the current Enterprise Value for Bionomics Limited (BNOEF) compare to its historical average?